This announcement is a separate document:
千红制药:独立董事 2023年度述职报告(徐光华)
Changzhou Qianhong Biopharma: Independent Director's 2023 Debriefing Report (Xu Guanghua)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.